Can Fite Biopharma Ltd (CANF) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.00x
Can Fite Biopharma Ltd (CANF) has a Cash Flow Reinvestment Rate of 0.00x as of June 2023, reinvesting ILA0.00 (capex ILA0.00 ) from operating cash flow of ILA95.00K. Explore CANF operating cash flow to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
ILA0.00
Capex + Investments
Operating Cash Flow
ILA95.00K
ILA
Capital Expenditures
ILA0.00
ILA
Annual Cash Flow Reinvestment Rate for Can Fite Biopharma Ltd (None–None)
Year-by-year capital reinvestment analysis for Can Fite Biopharma Ltd. For live market cap and broader valuation context, see market cap of Can Fite Biopharma Ltd.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow